Search

Author/Creator Tromp, Brenda

1. Corticosteroid tapering is a safe approach in patients with relapsed or refractory multiple myeloma receiving subcutaneous daratumumab: part 3 of the open-label, multicenter, phase 1b PAVO study. Issue 2 (28th January 2023)

Authors:
Nahi, Hareth; Usmani, Saad Z.; Mateos, Maria-Victoria; van de Donk, Niels W. C. J.; Oriol, Albert; Plesner, Torben; Bandyopadhyay, Nibedita; Hellemans, Peter; Tromp, Brenda; Nnane, Ivo; Zemlickis, Donna; Chari, Ajai; Moreau, Philippe
Journal:
Leukemia & lymphoma
Issue:
Volume 64:Issue 2(2023)
Page Start:
468
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Daratumumab, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone alone in newly diagnosed multiple myeloma (MAIA): overall survival results from a randomised, open-label, phase 3 trial. Issue 11 (November 2021)

Authors:
Facon, Thierry; Kumar, Shaji K; Plesner, Torben; Orlowski, Robert Z; Moreau, Philippe; Bahlis, Nizar; Basu, Supratik; Nahi, Hareth; Hulin, Cyrille; Quach, Hang; Goldschmidt, Hartmut; O'Dwyer, Michael; Perrot, Aurore; Venner, Christopher P; Weisel, Katja; Mace, Joseph R; Raje, Noopur; Tiab, Mourad...
Journal:
Lancet oncology
Issue:
Volume 22:Issue 11(2021)
Page Start:
1582
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search